These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34932170)

  • 1. Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis.
    Ameijeiras Rodríguez C; Henriques SC; Sancho-Araiz A; Trocóniz IF; Almeida L; Silva NE
    Pharm Res; 2021 Dec; 38(12):2047-2063. PubMed ID: 34932170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide.
    Malm-Erjefält M; Ekblom M; Vouis J; Zdravkovic M; Lennernäs H
    Mol Pharm; 2015 Nov; 12(11):4166-73. PubMed ID: 26426736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach.
    Kambayashi A; Dressman JB
    J Pharm Sci; 2022 Jan; 111(1):135-145. PubMed ID: 34390740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
    Danielak D; Paszkowska J; Staniszewska M; Garbacz G; Terlecka A; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2023 May; 186():132-143. PubMed ID: 37015321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a semi-mechanistic model to identify the main sources of variability of metformin pharmacokinetics.
    Stage TB; Wellhagen G; Christensen MMH; Guiastrennec B; Brøsen K; Kjellsson MC
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):105-114. PubMed ID: 30267605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
    Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
    Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
    AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.
    Schall R; Luus HG; Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):323-8. PubMed ID: 7952792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Intra- and Intersubject Variability in Oral Drug Absorption in Human Bioequivalence Studies of 113 Generic Products.
    Sugihara M; Takeuchi S; Sugita M; Higaki K; Kataoka M; Yamashita S
    Mol Pharm; 2015 Dec; 12(12):4405-13. PubMed ID: 26568266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.
    Bermejo M; Paixão P; Hens B; Tsume Y; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Löbenberg R; Lee A; Frances A; Amidon GE; Yu A; Salehi N; Talattof A; Benninghoff G; Sun D; Kuminek G; Cavanagh KL; Rodríguez-Hornedo N; Amidon GL
    Mol Pharm; 2018 Dec; 15(12):5454-5467. PubMed ID: 30372084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
    el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
    Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping a critical eye on the science and the regulation of oral drug absorption: a review.
    Macheras P; Karalis V; Valsami G
    J Pharm Sci; 2013 Sep; 102(9):3018-36. PubMed ID: 23568812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations.
    Chryssafidis P; Tsekouras AA; Macheras P
    Pharm Res; 2021 Aug; 38(8):1345-1356. PubMed ID: 34341958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
    Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
    J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.